Mike Lam

Associate
Full contact info

Passions

Hockey

Exercise & Fitness

Crypto Assets

Technology

Experience

Vistagen Therapeutics – $100 Million Follow-on Offering of Common Stock, Pre-Funded Warrants and Two Tranches of Common Stock Warrants

October 4, 2023

Cooley advised the underwriters in Vistagen Therapeutics’ $100 million follow-on offering of common stock, pre-funded warrants, and two tranches of common stock warrants, with Jefferies, Stifel and William Blair acting as lead book-running managers. Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders. Partners Denny Won, Charlie Kim and Courtney Tygesson led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Courtney M.W. Tygesson
Partner, Chicago
Christine Turner
Associate, Colorado
Jesse Schulman
Associate, Washington DC
Mike Lam
Associate, Los Angeles Santa Monica
Carley Cruea
Associate, Washington DC

Related Practices & Industries

Sagimet Biosciences Announces Upsized $85 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized initial public offering of Sagimet Biosciences, a clinical-stage biotechnology company, at $85 million.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Natalie Karam
Partner, Palo Alto
Denny Won
Partner, San Francisco
Heidi A. Erlacher
Partner, Boston
Natasha Leskovsek
Of Counsel, Washington DC
David D. Kim
Associate, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Victoria Comesañas
Associate, Palo Alto
Thomas "TJ" Paxton
Associate, Boston
Kate Walther
Paralegal Specialist, San Diego

Related Practices & Industries

Apogee Therapeutics Announces Upsized $345.1 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized $345.1 million initial public offering of Apogee Therapeutics, a biotechnology company.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Kristin VanderPas
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Stephanie Gentile
Partner, New York
Geoffrey Spolyar
Partner, Boston
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Randy Sabett
Special Counsel, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Madison (JJ) Meng
Associate, San Francisco
Megan Drill
Associate, San Diego
Alessandra Murata
Partner, Palo Alto
Darah Protas
Associate, Washington DC
Mike Lam
Associate, Los Angeles Santa Monica
David Dalton
Associate, Los Angeles Santa Monica
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

IGM Biosciences – $97.5 Million Follow-on Offering and Concurrent Private Placement

June 22, 2023

Cooley advised the underwriters in IGM Biosciences’ $97.5 million public offering of 9,000,000 shares of non-voting common stock and 3,187,500 shares of voting common stock, each at the public offering price of $8.00 per share, as well as a $22.5 million concurrent private placement. IGM is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer, autoimmune and inflammatory diseases, and infectious diseases. Denny Won, Kristin VanderPas and Charlie Kim led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
Christine Turner
Associate, Colorado
Mike Lam
Associate, Los Angeles Santa Monica
Ron Metzger
Paralegal Specialist, San Francisco

Related Practices & Industries

Erasca – $100 Million Follow-on Offering

January 9, 2023

Cooley advised the underwriters in Erasca’s $100 million follow-on offering of 15,384,616 shares of common stock at a public offering price of $6.50 per share. Erasca is a clinical-stage biopharmaceutical company discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Partners Charlie Kim, Kristin VanderPas and Denny Won led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Julia Gage
Associate, San Francisco

Related Practices & Industries

View more

Memberships & affiliations

New York State Bar Association